Medical Devices

With new financing from Avenue Capital, Turn Therapeutics bets big on its novel skin therapy, GX-03, to tackle multi-billion dollar dermatology markets.

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

Private equity firm Southfield Capital has acquired a majority stake in Metric Search, aiming to dominate the high-stakes recruitment market for niche talent.

Cionic's Neural Sleeve 2, a wearable AI device, has been named a top innovation for revolutionizing mobility in patients with neurological conditions.

The CRDMO giant posted a 16.7% revenue jump in 2025, driven by a massive pipeline expansion and a strategic pivot to next-generation biologics.

Investors eye Cardinal Health's April 30 report for signs its aggressive diversification and specialty pharma push can sustain its powerful earnings momentum.

A new platform is launching to connect pharma companies directly with 70+ global regulators, promising to slash approval times and speed patient access.

A new Phase 2 trial is testing an inhaled version of a key IPF drug, aiming to reduce severe side effects and transform treatment for the fatal lung disease.

With new memberships, Prenuvo aims to standardize proactive MRI screening. Is this the future of health or a high-priced service with unproven benefits?

Global brand TENA launches reusable protective boxers, blending everyday style with advanced tech to challenge the long-held stigma of male bladder leaks.

Clarius launches T-Mode, an AI-powered training tool that demystifies heart and knee ultrasounds for frontline clinicians, promising faster diagnosis.

With a new $40M loan, Hyperfine is set to accelerate the rollout of its Swoop® system, bringing AI-powered brain imaging directly to the patient's bedside.

Sydnexis's eye drop trial shows high efficacy in children 3-12, positioning it as a potential first-of-its-kind FDA-approved drug for myopia.

The bioconjugate CRDMO reports record profits and a $1.49B backlog, fueled by tech innovation, strategic acquisitions, and global expansion.

Lifecore Biomedical secures its third major manufacturing deal in five months, signaling a strategic shift that could reshape the aesthetics supply chain.

With key trial enrollment complete, Pyxis Oncology refines its cancer drug MICVO for safety and prepares for pivotal data under a new, seasoned CEO.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

With a promising non-opioid drug and new leadership known for major deals, Persica Pharmaceuticals is poised to revolutionize back pain treatment.

A Letter of Support from Siemens Healthineers validates Imaginostics' quest to revolutionize MRI with AI, aiming for earlier, more objective disease detection.

New study shows AI can match invasive methods for plaque analysis, a major step towards non-invasively predicting and preventing heart attacks.